Diskussion om Food and Drug Administrations rolle, når tiderne skifter

Niels Keiding

Abstract

The prestigious journal Biostatistics published in July 2017 six solicited commentaries on the role of the U.S. Food and Drug Administration (FDA), as times change, with ever developing technical tools for clinical trials and their evaluation, with increased focus on personalised medicine (possibly aided by genetic testing), and on patient self-determination. Two were written by American economists, four by leading biostatisticians, mostly from the USA. This paper summarises these texts for a Danish audience.

Bidragets oversatte titelThe role of the Food and Drug Administration as times change
OriginalsprogDansk
ArtikelnummerV11170868
TidsskriftUgeskrift for Laeger
Vol/bind180
Udgave nummer12
Sider (fra-til)1061-1063
Antal sider3
ISSN0041-5782
StatusUdgivet - 2018

Fingeraftryk

Dyk ned i forskningsemnerne om 'Diskussion om Food and Drug Administrations rolle, når tiderne skifter'. Sammen danner de et unikt fingeraftryk.

Citationsformater